JNK inhibitors
US7432375B2 · kind B2 · utility
40Cited by
1References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 2004 |
| Grant date | Oct 7, 2008 |
| Priority date | — |
| Expiry date | Mar 5, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel compounds of formula (I) and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.